finasteride has been researched along with Ventricular Dysfunction, Left in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bähre, H; Batkai, S; Bauersachs, J; Froese, N; Heineke, J; Hinz, H; Kaever, V; Kattih, B; Schmidtmann, E; Schmitto, JD; Szaroszyk, M; Thum, T; Widder, J; Zwadlo, C | 1 |
1 other study(ies) available for finasteride and Ventricular Dysfunction, Left
| Article | Year |
|---|---|
Antiandrogenic therapy with finasteride attenuates cardiac hypertrophy and left ventricular dysfunction.
Topics: Androgen Antagonists; Animals; Animals, Newborn; Cardiomegaly; Cells, Cultured; Female; Finasteride; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Ventricular Dysfunction, Left | 2015 |